Showing results (71-80 of 89) with videos related to
Sort By:
Pageof 9
Cancer Letters|February 27, 2025
SQLE-catalyzed squalene metabolism promotes mitochondrial biogenesis and tumor development in K-ras-driven cancerJunchen Pan, Rui Liu, Wenhua Lu, et al.Hepatology International|November 29, 2021
Health-related quality of life improves after entecavir treatment in patients with compensated HBV cirrhosisXiaoning Wu, Jia Hong, Jialing Zhou, et al.Alimentary Pharmacology & Therapeutics|October 28, 2025
Unstable Recompensation: An Intermediate Subtype in Patients With HBV-Related Decompensated CirrhosisShuai Xia, Zhiying He, Xiaoning Wu, et al.Hepatology (Baltimore, Md.)|September 1, 2025
Early on-treatment LSM reliably predicts liver-related events in CHB patients with significant fibrosis and cirrhosisYameng Sun, Shuyan Chen, Xiaoqian Xu, et al.Journal of Hepatology|December 10, 2019
PSMP/MSMP promotes hepatic fibrosis through CCR2 and represents a novel therapeutic targetShaoping She, Xiaoning Wu, Danfeng Zheng, et al.Hepatology International|January 18, 2021
Prediction of liver-related events in patients with compensated HBV-induced cirrhosis receiving antiviral therapyXiaoning Wu, Jialing Zhou, Yameng Sun, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 14, 2025
The Optimal Cutoffs of Liver Stiffness Measurement for Staging Fibrosis in On-treatment Patients With Chronic Hepatitis BXiaoning Wu, Jialing Zhou, Yameng Sun, et al.Liver International : Official Journal of the International Association for the Study of the Liver|December 5, 2020
Screening varices in patients with HBV-related cirrhosis on antiviral therapy: Platelet alone or together with LSMBingqiong Wang, Jialing Zhou, Xiaoning Wu, et al.Liver International : Official Journal of the International Association for the Study of the Liver|November 10, 2017
On-treatment changes of liver stiffness at week 26 could predict 2-year clinical outcomes in HBV-related compensated cirrhosisShanshan Wu, Yuanyuan Kong, Hongxin Piao, et al.Expert Opinion on Biological Therapy|August 1, 2018
Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label studyXiaoning Wu, Yiwen Shi, Jialing Zhou, et al.Pageof 9